Teladoc Faces Bumpy Path Despite Long-Term Growth Potential in Telehealth
• Teladoc struggled after initial pandemic demand faded - revenue growth slowed, still not profitable, facing stiff competition
• But Teladoc has competitive advantages - large member base, doctor network, benefits from network effects
• Massive growth potential remains in mental health and chronic care markets
• Teladoc stock looks undervalued based on forward price-to-sales ratio
• Worth investing now if willing to be patient for a comeback over time